Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT

Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT

Background: The omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) and aspirin both have proof of concept for colorectal cancer (CRC) chemoprevention, aligned with an excellent safety profile. Objectives: The objectives were to determine whether or not EPA prevents colorectal adenomas, e...

Full description

Bibliographic Details
Main Authors: Mark A Hull, Kirsty Sprange, Trish Hepburn, Wei Tan, Aisha Shafayat, Colin J Rees, Gayle Clifford, Richard F Logan, Paul M Loadman, Elizabeth A Williams, Diane Whitham, Alan A Montgomery
Format: Article
Language:English
Published: NIHR Journals Library 2019-06-01
Series:Efficacy and Mechanism Evaluation
Subjects:
ASPIRIN
COLORECTAL ADENOMA
COLORECTAL CANCER
EICOSAPENTAENOIC ACID
OMEGA-3 POLYUNSATURATED FATTY ACID
Online Access:https://doi.org/10.3310/eme06040

Internet

https://doi.org/10.3310/eme06040

Similar Items